{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:49:47Z","timestamp":1761929387319},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.bcp.2008.06.019","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T19:33:31Z","timestamp":1215459211000},"page":"608-619","source":"Crossref","is-referenced-by-count":15,"title":["Mutational study of the \u201ccatalytic tetrad\u201d of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance"],"prefix":"10.1016","volume":"76","author":[{"given":"Rosario","family":"Diaz-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"P\u00e9rez-Pertejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2008.06.019_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2014current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bcp.2008.06.019_bib2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/13543784.14.11.1337","article-title":"Clinical status of agents being developed for leishmaniasis","volume":"14","author":"Berman","year":"2005","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.bcp.2008.06.019_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-3623(97)00268-1","article-title":"The pharmacology of leishmaniasis","volume":"30","author":"Bala\u00f1a-Fouce","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.bcp.2008.06.019_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2008.06.019_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.bcp.2008.06.019_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2008.06.019_bib7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.279.5356.1504","article-title":"Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA","volume":"279","author":"Redinbo","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2008.06.019_bib8","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1074\/jbc.271.13.7602","article-title":"The domain organization of DNA topoisomerase I","volume":"271","author":"Stewart","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib9","doi-asserted-by":"crossref","first-page":"32950","DOI":"10.1074\/jbc.274.46.32950","article-title":"A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay","volume":"274","author":"Stewart","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib10","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1073\/pnas.1330762100","article-title":"An unusual type IB topoisomerase from African trypanosomes","volume":"100","author":"Bodley","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.06.019_bib11","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbaexp.2006.03.006","article-title":"DNA topoisomerase I from parasitic protozoa: a potential target for chemotherapy","volume":"1759","author":"Reguera","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2008.06.019_bib13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2958.2006.05428.x","article-title":"Topoisomerases of kinetoplastid parasites: why so fascinating?","volume":"62","author":"Das","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bcp.2008.06.019_bib14","first-page":"1035","article-title":"Catalytic mechanism of DNA topoisomerase IB","volume":"5","author":"Krogh","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2008.06.019_bib15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jmb.2006.01.022","article-title":"The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA","volume":"357","author":"Davies","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bcp.2008.06.019_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/nar\/19.1.69","article-title":"Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites","volume":"19","author":"Tamura","year":"1991","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bcp.2008.06.019_bib17","doi-asserted-by":"crossref","first-page":"22322","DOI":"10.1016\/S0021-9258(18)41531-1","article-title":"Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants","volume":"268","author":"Knab","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib18","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.49.4.1441-1446.2005","article-title":"Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani","volume":"49","author":"Marquis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2008.06.019_bib19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.biochi.2007.07.015","article-title":"Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani","volume":"89","author":"D\u00edaz-Gonz\u00e1lez","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2008.06.019_bib20","doi-asserted-by":"crossref","first-page":"31519","DOI":"10.1074\/jbc.273.47.31519","article-title":"Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA","volume":"273","author":"Hann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib21","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bcp.2008.06.019_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.1112680","article-title":"The genome of the kinetoplastid parasite, Leishmania major","volume":"309","author":"Ivens","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2008.06.019_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/JB.153.1.163-168.1983","article-title":"Transformation of intact yeast cells treated with alkali cations","volume":"153","author":"Ito","year":"1983","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bcp.2008.06.019_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0076-6879(90)82015-T","article-title":"Preparation of extracts from yeast","volume":"182","author":"Jazwinski","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bcp.2008.06.019_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2008.06.019_bib26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0021-9258(17)43412-0","article-title":"Identification of Saccharomyces cerevisiae mutants deficient in DNA topoisomerase I activity","volume":"259","author":"Thrash","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/mol.104.003889","article-title":"Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison","volume":"67","author":"Antony","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2008.06.019_bib28","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1074\/jbc.M110484200","article-title":"Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin","volume":"277","author":"Woo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/nar\/26.2.490","article-title":"Replacement of the active site tyrosine of vaccinia DNA topoisomerase by glutamate, cysteine or histidine converts the enzyme into a site-specific endonuclease","volume":"26","author":"Wittschieben","year":"1998","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bcp.2008.06.019_bib30","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1074\/jbc.M309959200","article-title":"The role of lysine 532 in the catalytic mechanism of human topoisomerase I","volume":"279","author":"Interthal","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib31","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.06.019_bib32","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"Staker","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.06.019_bib33","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1073\/pnas.86.10.3559","article-title":"Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I","volume":"86","author":"Lynn","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.06.019_bib34","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1093\/nar\/gkl670","article-title":"The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant","volume":"34","author":"Fiorani","year":"2006","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bcp.2008.06.019_bib35","doi-asserted-by":"crossref","first-page":"43268","DOI":"10.1074\/jbc.M303899200","article-title":"Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I","volume":"278","author":"Fiorani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0006-291X(92)91094-7","article-title":"Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line","volume":"188","author":"Kubota","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2008.06.019_bib37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/mol.56.6.1105","article-title":"Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity","volume":"56","author":"Fiorani","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2008.06.019_bib38","doi-asserted-by":"crossref","first-page":"12801","DOI":"10.1074\/jbc.272.19.12801","article-title":"Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle","volume":"272","author":"Megonigal","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.06.019_bib39","first-page":"504","article-title":"Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site","volume":"61","author":"Urasaki","year":"2001","journal-title":"Cancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208004243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208004243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T23:21:51Z","timestamp":1631488911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295208004243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0006295208004243"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2008.06.019","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}